MetLife Investment Management LLC Buys 2,727 Shares of UroGen Pharma Ltd. (NASDAQ:URGN)
MetLife Investment Management LLC increased its stake in UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) by 13.6% during the fourth quarter, HoldingsChannel reports. The firm owned 22,766 shares of the company’s stock after acquiring an additional 2,727 shares during the period. MetLife Investment Management LLC’s holdings in UroGen Pharma were worth $242,000 as of its […]
